Showing results (471-480 of 645) with videos related to

Sort By:
Pageof 65
Thrombosis and Haemostasis|October 1, 1991
Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosisH R Lijnen, J M Stassen, I Vanlinthout, et al.
Thrombosis and Haemostasis|March 30, 2000
Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in miceM Dewerchin, Z Liang, L Moons, et al.
Journal of Virology|June 1, 1984
Multiple proteases in foot-and-mouth disease virus replicationJ N Burroughs, D V Sangar, B E Clarke, et al.
Thrombosis and Haemostasis|May 24, 2000
Outcome and one year follow-up of intra-arterial staphylokinase in 191 patients with peripheral arterial occlusionS Heymans, S Vanderschueren, R Verhaeghe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Alpha-thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cellsM A Shatos, T Orfeo, J M Doherty, et al.
European Journal of Biochemistry|April 1, 1992
Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinaseA M Vandamme, M Dewerchin, H R Lijnen, et al.
Thrombosis and Haemostasis|March 4, 1991
Fibrinolysis and coagulation in patients with infectious disease and sepsisJ Philippé, F Offner, P J Declerck, et al.
The Journal of Biological Chemistry|April 15, 1993
On the mechanism of the activation of human plasminogen by recombinant staphylokinaseD Collen, B Schlott, Y Engelborghs, et al.
The Journal of Biological Chemistry|September 25, 1989
Characterization of the binding of human tissue-type plasminogen activator to plateletsD E Vaughan, M E Mendelsohn, P J Declerck, et al.
Circulation|April 1, 1987
Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprololF Van de Werf, J Vanhaecke, I K Jang, et al.
Pageof 65